We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Harrow Inc | NASDAQ:HROW | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.39 | 1.17% | 33.85 | 33.45 | 33.88 | 34.445 | 33.04 | 33.76 | 277,666 | 00:39:47 |
From Jul 2024 to Jan 2025
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York:
H.C. Wainwright 26th Annual Global Investment Conference (Lotte New York Palace Hotel) September 9-11, 2024 Company will present at 8:00 a.m. ET on September 10, 2024
Lake Street 8th Annual Best Ideas Growth Conference – Big 8 (The Yale Club) September 12, 2024 1x1 Meetings Only
Cantor 2024 Global Healthcare Conference (InterContinental New York Barclay Hotel) September 17-19, 2024 Company will host a Fireside Chat at 2:30 p.m. ET on September 18, 2024
The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. To listen to the audio webcast of either the H.C. Wainwright or Cantor conferences, please visit the Company’s website. The Lake Street conference will not be webcast.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903179422/en/
Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737
1 Year Harrow Chart |
1 Month Harrow Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
